EFFECT OF ERYTHROPOIETIN ON RENAL EXCRETION OF A SODIUM LOAD

被引:7
作者
BUNKE, M [1 ]
GLEASON, JR [1 ]
BRIER, M [1 ]
SLOAN, R [1 ]
机构
[1] UNIV LOUISVILLE,DEPT MED,DIV NEPHROL,LOUISVILLE,KY 40292
关键词
D O I
10.1038/clpt.1994.70
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To determine whether erythropoietin alters the renal excretion of a sodium load in humans, we administered either erythropoietin (150 units/kg) or vehicle intravenously in a randomized crossover design to six normal white men on day 4 of a controlled sodium diet. After erythropoietin administration, the subjects were given 2 L normal saline solution intravenously over 4 hours. All urine was collected for 4 days after drug administration. Serum sodium and creatinine levels and blood pressure were determined 0, 4, 8, and 24 hours after drug administration. Peripheral renin activity and aldosterone levels were determined 0, 4, and 8 hours after drug administration. Erythropoietin significantly decreased total sodium excretion during the 4 days after drug administration (erythropoietin = 784 +/- 46 mEq/4 days versus control = 840 +/- 41 mEq/4 days; p < 0.001). Erythropoietin did not alter creatinine clearance, blood pressure, or the changes in plasma renin activity and aldosterone caused by the saline load. We conclude that erythropoietin decreases urine sodium excretion after a sodium load in normal human subjects without altering glomerular filtration rate, blood pressure, or plasma renin activity.
引用
收藏
页码:563 / 568
页数:6
相关论文
共 29 条
[1]   RENAL-FUNCTION DURING ERYTHROPOIETIN THERAPY FOR ANEMIA IN PREDIALYSIS CHRONIC-RENAL-FAILURE PATIENTS [J].
ABRAHAM, PA ;
OPSAHL, JA ;
RACHAEL, KM ;
ASINGER, R ;
HALSTENSON, CE .
AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 (02) :128-136
[2]   ERYTHROPOIETIN HAS A MITOGENIC AND POSITIVE CHEMOTACTIC EFFECT ON ENDOTHELIAL-CELLS [J].
ANAGNOSTOU, A ;
LEE, ES ;
KESSIMIAN, N ;
LEVINSON, R ;
STEINER, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (15) :5978-5982
[3]   RELATIVE CONTRIBUTIONS OF DIETARY NA+ AND CL- TO SALT-SENSITIVE HYPERTENSION [J].
BOEGEHOLD, MA ;
KOTCHEN, TA .
HYPERTENSION, 1989, 14 (06) :579-583
[4]  
BRIER ME, 1993, J AM SOC NEPHROL, V3, P1583
[5]   INFLUENCE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON BLOOD-PRESSURE AND TISSUE RENIN-ANGIOTENSIN SYSTEMS [J].
EGGENA, P ;
WILLSEY, P ;
JAMGOTCHIAN, N ;
TRUCKENBROD, L ;
HU, MS ;
BARRETT, JD ;
EGGENA, MP ;
CLEGG, K ;
NAKHOUL, F ;
LEE, DBN .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (05) :E642-E646
[6]   TREATMENT OF THE ANEMIA OF PROGRESSIVE RENAL-FAILURE WITH RECOMBINANT HUMAN ERYTHROPOIETIN [J].
ESCHBACH, JW ;
KELLY, MR ;
HALEY, NR ;
ABELS, RI ;
ADAMSON, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) :158-163
[7]   RECOMBINANT HUMAN ERYTHROPOIETIN IN ANEMIC PATIENTS WITH END-STAGE RENAL-DISEASE - RESULTS OF A PHASE-III MULTICENTER CLINICAL-TRIAL [J].
ESCHBACH, JW ;
ABDULHADI, MH ;
BROWNE, JK ;
DELANO, BG ;
DOWNING, MR ;
EGRIE, JC ;
EVANS, RW ;
FRIEDMAN, EA ;
GRABER, SE ;
HALEY, NR ;
KORBET, S ;
KRANTZ, SB ;
LUNDIN, AP ;
NISSENSON, AR ;
OGDEN, DA ;
PAGANINI, EP ;
RADER, B ;
RUTSKY, EA ;
STIVELMAN, J ;
STONE, WJ ;
TESCHAN, P ;
VANSTONE, JC ;
VANWYCK, DB ;
ZUCKERMAN, K ;
ADAMSON, JW .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (12) :992-1000
[8]   RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR PATIENTS WITH AIDS TREATED WITH ZIDOVUDINE [J].
FISCHL, M ;
GALPIN, JE ;
LEVINE, JD ;
GROOPMAN, JE ;
HENRY, DH ;
KENNEDY, P ;
MILES, S ;
ROBBINS, W ;
STARRETT, B ;
ZALUSKY, R ;
ABELS, RI ;
TSAI, HC ;
RUDNICK, SA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (21) :1488-1493
[9]   PHARMACOKINETICS AND ERYTHROPOIETIC RESPONSE TO HUMAN RECOMBINANT ERYTHROPOIETIN IN HEALTHY-MEN [J].
FLAHARTY, KK ;
CARO, J ;
ERSLEV, A ;
WHALEN, JJ ;
MORRIS, EM ;
BJORNSSON, TD ;
VLASSES, PH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (05) :557-564
[10]  
FRENKEN LAM, 1989, NEPHROL DIAL TRANSPL, V4, P782